We are live on ! Find out more

15 hedge funds and large institutions have $3.2M invested in PAVmed in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

25% more capital invested

Capital invested by funds: $2.55M → $3.2M (+$644K)

0% more funds holding

Funds holding: 1515 (0)

0% less ownership

Funds ownership: 0.01%0.01% (-0%)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

Holders
15
Holders Change
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change

PAVM Hedge Fund Activity: Q4 2019 in Review

15 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q4 2019, worth a combined $3.2M — up 25% from $2.55M a quarter earlier.

Fund positioning in PAVM was balanced in Q4 2019: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 1 trimmed.

The largest buyer was Levin Capital Strategies, adding an estimated $46.2K. The largest seller was Citadel Advisors, exiting entirely with an estimated $26K sold.

  • 15 institutional investors held PAVmed (PAVM) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $3.2M of PAVmed stock for Q4 2019, up 25% quarter-over-quarter.
  • 4 funds opened new PAVmed positions in Q4 2019 and 4 closed out, a net change of 0 holders.
  • The largest PAVmed buyer in Q4 2019 was Levin Capital Strategies, an estimated $46.2K added.
  • The largest PAVmed seller in Q4 2019 was Citadel Advisors, an estimated $26K sold.

Based on aggregated 13F filings for Q4 2019.